Dysis ii acs china
WebProducts. DYSIS Medical is a forward-looking medical technology company that combines innovative computer-aided cervical mapping with an advanced colposcope design to help … WebUsing data from the observational DYSIS II study, we sought to evaluate the use of guideline-recommended treatments at discharge for acute coronary syndromes (ACS) or in the chronic phase for CHD, and participation in …
Dysis ii acs china
Did you know?
WebWith advanced DYSIS colposcopy exams, acetowhitening is objectively quantified, which can help reduce the risk of missing high-grade disease. 4. 3. DeNardis et al. Int J … WebA large observational study (DYSIS-China) showed that although the majority ... In the DYSIS II ACS cohort, 11 although 94.6% of patients still used statins 4 months after discharge, the statin dosage decreased from 37 mg during the hospital stay to 32±21 mg/day by the follow-up visit. Despite this comparatively high dose of statin, attainment ...
WebAug 29, 2024 · Despite major progress in the diagnosis and treatment, cardiovascular disease (CVD) remains a leading cause of death, premature disability and increasing healthcare costs worldwide. According to the World Health Organization, of the 56.4 m deaths in 2015, CVD accounted for 15 m, around 7.4 m from coronary heart disease … National Center for Biotechnology Information
WebNov 25, 2024 · The Dyslipidemia International Study (DYSIS II) prospectively collected data of patients with chronic coronary syndromes (CCS) and acute coronary syndromes … WebAug 28, 2024 · Background: The objective of the second Dyslipidemia International Study (DYSIS II) was to document use of lipid-lowering therapies (LLTs), LDL-C target value a We use cookies to enhance your experience on our website.By continuing to use our website, you are agreeing to our use of cookies.
WebDysis Inc was founded in 1993, and is located at 12024 Sunrise Valley Dr in Reston. Additional information is available at or by contacting Joseph Lenning at (703) 715-3018.
WebThe DYSIS II Europe study which included patients with coronary heart disease (CHD) and survivors of acute coronary syndrome (ACS) from 7 European countries (Belgium, France, Germany, Greece, Ireland, Italy, and Russia) showed that only 28.3% of CHD patients and 15.7% of ACS patients had attained the target LDL cholesterol level of <70 mg/dL. however tlumaczWebJan 30, 2024 · DYSIS represents a technological advancement in the identification and management of cervical dysplasia and cancer prevention." Jeff Livingston MD, FACOG … hide from address lists attributeWebApr 10, 2024 · The Dyslipidemia International Study (DYSIS) II was a multinational observational study involving subjects with stable CHD and those being hospitalized with an ACS. The present ... considered to be at very high-risk due to the ACS event, LDL-C target attainment was evaluated for any subjects with a repeat lipid profile available. however ultimatelyWebNov 25, 2024 · A total of 7,865 patients were enrolled into DYSIS II, 6,794 had CCS and 1,071 ACS. Under the documented statin treatment in DYSIS only 12.7% of patients reached an LDL-C <55mg/dl. Putting all patients on high dose statins in combination with ezetimibe, 64.1% would reach the target. hide from address listsWebContemporary data from the DYSIS II ACS/CHD study These observational data show the progress made in the treatment of ACS from the acute phase up to 3 months, and highlight key areas for improvement in the prevention of recurrent events in patients with CHD in … however traduireWebNov 1, 2024 · Using data from the observational DYSIS II study, we sought to evaluate the use of guideline-recommended treatments at discharge for acute coronary syndromes (ACS) or in the chronic phase for CHD, and participation in rehabilitation/secondary prevention programs. Methods and results however until nowWebACS patients had a repeat lipid test during the follow-up period. Although LDL cholesterol target attainment had improved after discharge, only two-fifths (42%) of patients achieved LDL cholesterol <70mg/dl during the follow-up. The DYSIS II results are in accordance with other multinational surveys in the Asia-Pacific region, hide from a broken heart by dallas smith